Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
Navjotsingh Pabla(The Ohio State University), Alex Sparreboom(The Ohio State University), Giuliano Ciarimboli(University Hospital Münster), Lie Li(Qingdao University), Jason A. Sprowl(University at Buffalo, State University of New York), Alice A. Gibson(The Ohio State University), Guoqing Du(Inner Mongolia University), Shuiying Hu(The Ohio State University), Laura J. Janke(St. Jude Children's Research Hospital), Eberhard Schlatter(Boston University), Taosheng Chen(St. Jude Children's Research Hospital), Aksana Vasilyeva, Su Sien Ong
Cited by 110
Related Papers
Cremophor EL
|European Journal of Cancer|2001|1.6k
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
|PubMed|2001|752